Search Results - Colleen Burns

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Sustained Weight Loss Following 12-Month Pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity

    Sustained Weight Loss Following 12-Month Pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity by Steven R. Smith, Louis J. Aronne, Colleen Burns, Nicole C. Kesty, Amy E. Halseth, Christian Weyer

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials

    Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials by Ralph A. DeFronzo, John B. Buse, Terri Kim, Colleen Burns, Sharon Skare, Alain Baron, Mark Fineman

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes

    Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabete... by Priscilla Hollander, Alok Gupta, Raymond A Plodkowski, Frank L. Greenway, Harold Bays, Colleen Burns, Preston Klassen, Ken Fujioka

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies

    The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies by John B. Buse, Ralph A. DeFronzo, Julio Rosenstock, Terri Kim, Colleen Burns, Sharon Skare, Alain Baron, Mark Fineman

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)

    A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II) by Caroline M. Apovian, Louis J. Aronne, Domenica Rubino, Christopher D. Still, Holly R. Wyatt, Colleen Burns, Dennis Kim, Eduardo Dunayevich

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes

    Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes by Ian Chapman, Barbara A. Parker, S. Doran, Christine Feinle‐Bisset, Jocelyn Wishart, S. Strobel, Y. Wang, Colleen Burns, Cameron W. Lush, C. Weyer, Michael Horowitz

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Progressive Reduction in Body Weight after Treatment with the Amylin Analog Pramlintide in Obese Subjects: A Phase 2, Randomized, Placebo-Controlled, Dose-Escalation Study

    Progressive Reduction in Body Weight after Treatment with the Amylin Analog Pramlintide in Obese Subjects: A Phase 2, Randomized, Placebo-Controlled, Dose-Escalation Study by Louis J. Aronne, Ken Fujioka, Vanita R. Aroda, Kim Chen, Amy E. Halseth, Nicole C. Kesty, Colleen Burns, Cameron W. Lush, Christian Weyer

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: